These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1703368)
1. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Petit MA; Dubanchet S; Capel F; Voet P; Dauguet C; Hauser P Virology; 1991 Feb; 180(2):483-91. PubMed ID: 1703368 [TBL] [Abstract][Full Text] [Related]
2. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope. Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. Petit MA; Strick N; Dubanchet S; Capel F; Neurath AR Mol Immunol; 1991; 28(4-5):517-21. PubMed ID: 1712075 [TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus. Petit MA; Dubanchet S; Capel F Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766 [TBL] [Abstract][Full Text] [Related]
5. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Petit MA; Capel F; Dubanchet S; Mabit H Virology; 1992 Mar; 187(1):211-22. PubMed ID: 1736525 [TBL] [Abstract][Full Text] [Related]
6. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions. Zhang J; Wang Q; Yuan W; Li J; Yuan Q; Zhang J; Xia N; Wang Y; Li J; Tong S J Virol; 2024 Aug; 98(8):e0192923. PubMed ID: 39078152 [TBL] [Abstract][Full Text] [Related]
7. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Neurath AR; Seto B; Strick N Vaccine; 1989 Jun; 7(3):234-6. PubMed ID: 2476893 [TBL] [Abstract][Full Text] [Related]
9. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866 [TBL] [Abstract][Full Text] [Related]
10. Detection of receptors for hepatitis B virus on cells of extrahepatic origin. Neurath AR; Strick N; Sproul P; Ralph HE; Valinsky J Virology; 1990 Jun; 176(2):448-57. PubMed ID: 2161145 [TBL] [Abstract][Full Text] [Related]
11. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response. Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500 [TBL] [Abstract][Full Text] [Related]
12. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences. Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154 [TBL] [Abstract][Full Text] [Related]
13. Attachment sites and neutralising epitopes of hepatitis B virus. Glebe D Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes. Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail. Neurath AR; Strick N; Girard M Mol Immunol; 1989 Jan; 26(1):53-62. PubMed ID: 2467197 [TBL] [Abstract][Full Text] [Related]
16. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site. Wi J; Jeong MS; Hong HJ J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661 [TBL] [Abstract][Full Text] [Related]
17. Assay of preS epitopes and preS1 antibody in hepatitis B virus carriers and immune persons. Deepen R; Heermann KH; Uy A; Thomssen R; Gerlich WH Med Microbiol Immunol; 1990; 179(1):49-60. PubMed ID: 1691815 [TBL] [Abstract][Full Text] [Related]
18. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library. Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315 [TBL] [Abstract][Full Text] [Related]
19. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Gerken G; Kremsdorf D; Capel F; Petit MA; Dauguet C; Manns MP; Meyer zum Büschenfelde KH; Brechot C Virology; 1991 Aug; 183(2):555-65. PubMed ID: 1853561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]